PReferentially Expressed Antigen in MElanoma (PRAME): preliminary communication on a translational tool able to early detect Oral Malignant Melanoma (OMM)

Eliano Cascardi, Gerardo Cazzato, Giuseppe Ingravallo, Miriam Dellino, Carmelo Lupo, Nadia Casatta, Andrea Ballini, Andrea Pacifici, Gaetano Marenzi, Gilberto Sammartino, Eugenio Maiorano, Marco Tatullo (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

77 Downloads (Pure)

Abstract

Oral malignant melanoma (OMM) has a prevalence less than 1% of all melanomas and it commonly develops on the oral mucosa following a slow and unspecific transformation of unstable melanocytic lesions, often resulting in a diagnostic delay. The marker PReferentially Expressed Antigen in MElanoma (PRAME) seems to be a valid tool to investigate the biological and histological nature of cutaneous melanocytic lesions, but to date its use to characterize pigmented lesions in the oral cavity is largely unexplored. The aim of this study was to create preliminary knowledge on the PRAME expression in OMM, and to compare its expression respect to other dysplastic pigmented lesions of the oral cavity. Interestingly, PRAME has been demonstrated to be reliable in the clinical conditions investigated in our pilot study; in fact, it has clearly differentiated the cases of Melanoma, which showed diffuse and intense positivity (score 6+/7+) to PRAME, from the other melanocytic nevi, which resulted to be mainly negative to PRAME. This means a better differential diagnosis, a reliable early diagnosis and a proper clinical/surgical management of the oncological lesions. In conclusion, PRAME can be a valid qualitative marker for differential diagnosis, not only in cutaneous melanomas, but also in malignant melanoma of the entire head and neck area.

Original languageEnglish
Pages (from-to)628-633
Number of pages6
JournalJournal of Cancer
Volume14
Issue number4
DOIs
Publication statusPublished - 27 Feb 2023

Keywords

  • Differential Diagnosis
  • Early diagnosis
  • Oral Malignant Melanoma

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'PReferentially Expressed Antigen in MElanoma (PRAME): preliminary communication on a translational tool able to early detect Oral Malignant Melanoma (OMM)'. Together they form a unique fingerprint.

Cite this